Overview

Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation

Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study was to evaluate the protective effect of dexmedetomidine on myocardial injury during liver transplantation
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Tianjin First Central Hospital
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- End stage liver disease scheduled for liver transplantation in Tianjin First Center
Hospital

Exclusion Criteria:

- Pre-existing respiratory failure,renal failure,hepatic encephalopathy